Pan American Network on Drug regulatory Harmonization WG/Medicinal Plants. II Meeting 29-31, March Curitiba, Brazil . Background in the Americas I. Regional Experts Meeting Jamaica (Nov 2000) Requirements for registration of MP Concept of MP . Regional Experts Meeting (2000) Participants.
Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author.While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server.
5. To establish a specific post marketing surveillance on the use of HM as part of the general drug post marketing surveillance program;
6. To develop standards of good botanical practices to guarantee that each lot of raw material or plant material used to make a herbal drug should be completely identified. The creation of a herbal of reference is to be the responsibility of the manufacturer or supplier of raw material.
(2) Quality control of HM;
(3) Safety monitoring of HM;
(4) Rational use of traditional medicines; and
(5) Challenges for regulatory harmonization in the field of quality control, safety monitoring and proper use of HM by consumers.
I meeting of the PANDRH WG on Medicinal Plants